Welcome to Paid Research Studies

  • Conditions:   Endometritis;   Cesarean Section; Infection;   Wound Infection
    Interventions:   Drug: Azithromycin 500 mg;   Drug: Mefoxin 2g
    Sponsor:   RWJ Barnabas Health at Jersey City Medical Center

  • Conditions:   Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Diseases
    Interventions:   Drug: Cefoxitin;   Drug: Piperacillin-tazobactam
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Indiana University;   Massachusetts General Hospital;   Thomas Jefferson University;   Washington University School of Medicine;   Advocate Illinois Masonic Medical Center;   Baptist Memorial Health Care Corporation;   Baylor Scott and White Health;   The Cleveland Clinic;   Emory University;   Fox Chase Cancer Center;   Gundersen Lutheran Medical Center;   Hackensack Meridian Health;   Hamilton Health Sciences Center;   Intermountain Health Care, Inc.;   Jersey Shore Medical Center (Hackensack Meridian);   Johns Hopkins University;   Montefiore Medical Center/Albert Einstein College of Medicine;   NorthShore University HealthSystem;   Milton S. Hershey Medical Center;   Rhode Island Hospital;   Stony Brook Medicine;   Sunnybrook Health Sciences Centre, Canada;   Temple University;   The Ohio State University Wexner Medical Center;   The Ottowa Hospital/University of Ottowa;   University of California, Davis;   University of Chicago;   University of Iowa;   University of Texas Southwestern Medical Center;   University of Utah;   University of Wisconsin, Madison;   Providence Health & Services;   Albany Medical College;   Northwestern University;   Universtiy of Mississippi Medical Center;   Mount Sinai Hospital, New York;   Brody School of Medicine at East Carolina University

  • Condition:   Appendicitis
    Interventions:   Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin;   Procedure: Appendectomy
    Sponsors:   University of Washington;   Patient-Centered Outcomes Research Institute